NuCana (NCNA) Profit After Tax (2017 - 2025)

NuCana (NCNA) reported Profit After Tax of -$1.3 million for Q3 2025, down 1440589313.39% on a YoY basis from N/an in Q3 2024, and up 96.03% sequentially from -$33.0 million in Q2 2025.

NuCana (NCNA) Profit After Tax (2017 - 2025) Analysis & Trends

NuCana (NCNA) has 9 years of Profit After Tax data on file, last reported at -$1.3 million in Q3 2025.

  • For the quarter ending Q3 2025, Profit After Tax fell 1440589313.39% year-over-year to -$1.3 million; the trailing twelve-month figure through Dec 2025 stood at -$38.4 million (down 220.06% YoY), and the FY2024 full-year result was -$0.33, up 100.0% from the prior year.
  • Profit After Tax rose to -$1.3 million in Q3 2025, from -$33.0 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$0.01 in Q4 2024 to a low of -$33.0 million in Q2 2025.
  • A 5-year average of -$10.2 million and a median of -$8.7 million in 2022 frame the typical range for Profit After Tax.
  • Across the five-year window, Profit After Tax jumped 100.0% in 2023 and slumped 20138079015.04% in 2025, its largest moves.
  • Tracing NCNA's Profit After Tax over 5 years: stood at -$24.0 million in 2021, then advanced by 8.42% to -$22.0 million in 2022, then jumped by 100.0% to -$0.17 in 2023, then surged by 92.61% to -$0.01 in 2024, then plunged by 10208248966.51% to -$1.3 million in 2025.
  • Business Quant data shows NCNA's Profit After Tax at -$1.3 million in Q3 2025, -$33.0 million in Q2 2025, and -$4.0 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -36.84 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 227.36 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -65.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -26.94 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 362.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -453.82 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 205.99 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 -1.31 Mn
Jun 30, 2025 -33.04 Mn
Mar 31, 2025 -4.00 Mn
Dec 31, 2024 -0.01
Sep 30, 2024 -0.09
Jun 30, 2024 -0.16
Mar 31, 2024 -11.98 Mn
Dec 31, 2023 -0.17
Sep 30, 2023 -0.16
Jun 30, 2023 -0.19
Mar 31, 2023 -11.98 Mn
Dec 31, 2022 -21.96 Mn
Sep 30, 2022 -8.74 Mn
Jun 30, 2022 -7.91 Mn
Mar 31, 2022 -16.73 Mn
Dec 31, 2021 -23.98 Mn
Sep 30, 2021 -16.35 Mn
Jun 30, 2021 -17.13 Mn
Mar 31, 2021 -18.15 Mn
Dec 31, 2020 -20.67 Mn